Pura Vida Investments, LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Pura Vida Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.2 - $14.24 $420,000 - $1.42 Million	-100,000 Reduced 12.01%	732,702 $4.95 Million
Q3 2022 Nov 14, 2022	BUY	$9.85 - $16.83 $195,758 - $334,479	19,874 Added 2.45%	832,702 $12.1 Million
Q2 2022 Aug 15, 2022	BUY	$8.16 - $15.1 $6.29 Million - $11.6 Million	771,435 Added 1863.68%	812,828 $8 Million
Q1 2022 May 16, 2022	BUY	$11.2 - $16.97 $3,427 - $5,192	306 Added 0.74%	41,393 $610,000
Q4 2021 Feb 14, 2022	BUY	$12.36 - $18.28 $236,558 - $349,860	19,139 Added 87.2%	41,087 $544,000
Q3 2021 Nov 15, 2021	BUY	$17.11 - $24.49 $34,083 - $48,784	1,992 Added 9.98%	21,948 $383,000
Q2 2021 Aug 16, 2021	SELL	$23.12 - $29.91 $6,959 - $9,002	-301 Reduced 1.49%	19,956 $478,000
Q1 2021 May 12, 2021	BUY	$14.69 - $42.57 $297,575 - $862,340	20,257 New	20,257 $520,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $220M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.